Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 33.3% increase over the number of companies inspected in the previous quarter, when six companies received six inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Devices and Drugs sectors sectors tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Colorcon, Inc. | Food and Cosmetics | 09/13/2023 | No Action Indicated (NAI) |
Elegant Foods, LLC | Food and Cosmetics | 07/28/2023 | Voluntary Action Indicated (VAI) |
Midwest Refrigerated Services, LLC | Food and Cosmetics | 07/11/2023 | No Action Indicated (NAI) |
NorthStar Medical Radioisotopes, LLC | Drugs | 09/08/2023 | No Action Indicated (NAI) |
Phillips Distributing Corporation | Food and Cosmetics | 07/11/2023 | No Action Indicated (NAI) |
Reciprocal Labs Corporation | Devices | 08/02/2023 | Voluntary Action Indicated (VAI) |
Spectrum Brands, Inc. | Devices | 08/04/2023 | No Action Indicated (NAI) |
University of Wisconsin System Radiopharmaceutical Production Facility | Drugs | 09/07/2023 | Voluntary Action Indicated (VAI) |